Health Care sector company Lantheus posted a -1.18% performance today, while the S&P 500 returned -0.23%.
8 analysts are following Lantheus and have set target prices ranging from $94.0 to $120.0 per share. On average, they have given the company a rating of buy. At today's prices, LNTH is trading -25.75% away from its average analyst target price of $108.38 per share.
Over the last year, LNTH's share price has increased by 42.07%, which represents a difference of 56.19% when compared to the S&P 500. The stock's 52 week high is $87.47 per share whereas its 52 week low is $47.46. With an average free cash flow of $38,295,400.0 that have been growing at an average rate of 27.88% over the last four years, Lantheus is in a position to continue its strong stock performance trend.
| Date Reported | Cash Flow from Operations (k) | Capital Expenditures (k) | Free Cash Flow (k) | YoY Growth |
|---|---|---|---|---|
| 2022-12-31 | $281,781 | $260,000 | $21,781 | -59.6% |
| 2021-12-31 | $53,916 | $0 | $53,916 | 228.84% |
| 2020-12-31 | $16,396 | $0 | $16,396 | -71.89% |
| 2019-12-31 | $80,384 | $22,061 | $58,323 | 42.04% |
| 2018-12-31 | $61,193 | $20,132 | $41,061 | n/a |
